# RASGRP1

## Overview
RASGRP1 is a gene that encodes the RAS guanyl releasing protein 1, a guanine nucleotide exchange factor (GEF) that plays a pivotal role in cellular signaling pathways, particularly in the immune system. The protein facilitates the activation of Ras-family proteins by promoting the exchange of GDP for GTP, thereby initiating the Ras-RAF-MEK-ERK signaling cascade. This pathway is crucial for the development, survival, and proliferation of T cells, as well as the function of B cells and natural killer (NK) cells (Salzer2016RASGRP1; Vercoulen2017A). Structurally, RAS guanyl releasing protein 1 contains several domains, including a catalytic CDC25 domain, a Ras exchange motif (REM), an EF domain, and a diacylglycerol (DAG)-binding C1 domain, which collectively regulate its activity and localization (Iwig2013Structural; Hsu2023A). Dysregulation or mutations in RASGRP1 are linked to immunological disorders, such as primary immunodeficiency and autoimmune diseases, highlighting its significance in maintaining immune homeostasis (Salzer2016RASGRP1; Molineros2019Mechanistic).

## Structure
RASGRP1 is a guanine nucleotide exchange factor (GEF) that plays a crucial role in activating Ras-family proteins. The protein's structure includes several key domains: a catalytic CDC25 domain, a Ras exchange motif (REM), an EF domain, and a diacylglycerol (DAG)-binding C1 domain. The CDC25 domain is responsible for facilitating the exchange of GDP for GTP on Ras, while the REM domain provides structural support (Iwig2013Structural; Hsu2023A).

The EF domain of RasGRP1 has calcium-binding capabilities, which can induce conformational changes necessary for activation. This domain is positioned between the CDC25 and C1 domains, contributing to the protein's regulatory mechanisms (Iwig2013Structural). The C1 domain binds DAG, anchoring RasGRP1 to the plasma membrane, which is essential for its function (Hsu2023A).

RasGRP1 is autoinhibited by an interdomain linker that blocks the Ras-binding site. Activation involves conformational changes triggered by increased intracellular pH, calcium, and DAG levels, which displace the linker and expose the active site (Iwig2013Structural; Vercoulen2017A). His 212 acts as a pH sensor, playing a critical role in the transition between inactive and active states (Vercoulen2017A).

## Function
RASGRP1 is a guanine nucleotide exchange factor (GEF) that plays a critical role in activating the Ras-RAF-MEK-ERK signaling pathway, which is essential for T cell development, survival, and proliferation. It is highly expressed in lymphoid cells, particularly T cells, where it is activated following T cell receptor (TCR) stimulation. This activation is dependent on diacylglycerol (DAG) and protein kinase C (PKC), which facilitate the translocation of RASGRP1 to the plasma membrane, where it converts Ras from an inactive GDP-bound state to an active GTP-bound state (Salzer2016RASGRP1; Vercoulen2017A).

RASGRP1 also plays a significant role in B cells and NK cells. In B cells, it is involved in activation and proliferation, with deficiencies leading to impaired MAPK pathway activation and reduced class-switch recombination. In NK cells, RASGRP1 is crucial for cytotoxic function, with deficiencies resulting in impaired granule convergence and defective immunological synapse formation (Salzer2016RASGRP1).

The protein contains a calcium-binding EF hand domain, and calcium binding induces allosteric changes that release autoinhibition, promoting its activity. RASGRP1's activity is also modulated by pH changes within the cell, with histidine 212 acting as a pH sensor that influences the protein's conformation and activity (Vercoulen2017A).

## Clinical Significance
Mutations and dysregulation of the RASGRP1 gene are associated with several immunological disorders and conditions. A deficiency in RASGRP1 can lead to a primary immunodeficiency characterized by impaired cytoskeletal dynamics, affecting T cells, B cells, and natural killer (NK) cells. This deficiency results in recurrent infections, failure to thrive, and susceptibility to Epstein-Barr virus (EBV)-associated lymphoproliferation and B cell lymphoma (Kuskonmaz2022First; Salzer2016RASGRP1). Patients with RASGRP1 deficiency exhibit CD4+ T cell lymphopenia, elevated CD8+ T cells, and impaired T cell proliferation, alongside decreased B cell counts and NK cell cytotoxicity (Salzer2016RASGRP1).

Alterations in RASGRP1 expression are also linked to autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Variants in the RASGRP1 gene can increase susceptibility to SLE by affecting gene expression and signaling pathways, leading to impaired lymphocyte function and increased apoptosis (Baars2020Dysregulated; Molineros2019Mechanistic). In RA, decreased RASGRP1 expression in CD4+ T cells correlates with disease severity, suggesting its role in autoimmunity (Baars2020Dysregulated). These findings underscore the critical role of RASGRP1 in maintaining immune system balance and its potential involvement in both immunodeficiency and autoimmunity.

## Interactions
RASGRP1 interacts with several proteins and plays a significant role in cellular signaling pathways. It binds to diacylglycerol (DAG) and calcium ions, which are crucial for its activation and function in T cells (Vercoulen2017A). The protein is also involved in interactions with the dynein light chain DYNLL1, which is important for cytoskeletal dynamics in immune cells. This interaction is essential for the proper functioning of the microtubule cytoskeleton, particularly in T cells and NK cells, where it affects processes like centrosome polarization and granule convergence (Salzer2016RASGRP1).

RASGRP1 forms a complex with the Grb2-SOS1 during negative selection in thymocytes, which activates the Ras pathway. This complex formation is crucial for the recruitment of RASGRP1 to the plasma membrane and its subsequent activation (Hsu2023A). Additionally, RASGRP1 interacts with the multifunctional protein hnRNP-K, which binds to specific SNPs in the RASGRP1 gene, influencing its expression and contributing to systemic lupus erythematosus (SLE) susceptibility (Molineros2019Mechanistic). These interactions highlight the diverse roles of RASGRP1 in immune cell function and its involvement in various signaling pathways.


## References


[1. (Molineros2019Mechanistic) Julio E. Molineros, Bhupinder Singh, Chikashi Terao, Yukinori Okada, Jakub Kaplan, Barbara McDaniel, Shuji Akizuki, Celi Sun, Carol F. Webb, Loren L. Looger, and Swapan K. Nath. Mechanistic characterization of rasgrp1 variants identifies an hnrnp-k-regulated transcriptional enhancer contributing to sle susceptibility. Frontiers in Immunology, May 2019. URL: http://dx.doi.org/10.3389/fimmu.2019.01066, doi:10.3389/fimmu.2019.01066. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2019.01066)

[2. (Salzer2016RASGRP1) Elisabeth Salzer, Deniz Cagdas, Miroslav Hons, Emily M Mace, Wojciech Garncarz, Özlem Yüce Petronczki, René Platzer, Laurène Pfajfer, Ivan Bilic, Sol A Ban, Katharina L Willmann, Malini Mukherjee, Verena Supper, Hsiang Ting Hsu, Pinaki P Banerjee, Papiya Sinha, Fabienne McClanahan, Gerhard J Zlabinger, Winfried F Pickl, John G Gribben, Hannes Stockinger, Keiryn L Bennett, Johannes B Huppa, Loïc Dupré, Özden Sanal, Ulrich Jäger, Michael Sixt, Ilhan Tezcan, Jordan S Orange, and Kaan Boztug. Rasgrp1 deficiency causes immunodeficiency with impaired cytoskeletal dynamics. Nature Immunology, 17(12):1352–1360, October 2016. URL: http://dx.doi.org/10.1038/ni.3575, doi:10.1038/ni.3575. This article has 112 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ni.3575)

[3. (Iwig2013Structural) Jeffrey S Iwig, Yvonne Vercoulen, Rahul Das, Tiago Barros, Andre Limnander, Yan Che, Jeffrey G Pelton, David E Wemmer, Jeroen P Roose, and John Kuriyan. Structural analysis of autoinhibition in the ras-specific exchange factor rasgrp1. eLife, July 2013. URL: http://dx.doi.org/10.7554/elife.00813, doi:10.7554/elife.00813. This article has 75 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.00813)

[4. (Baars2020Dysregulated) Matthijs J.D. Baars, Thera Douma, Dimitre R. Simeonov, Darienne R. Myers, Kayla Kulhanek, Saikat Banerjee, Susan Zwakenberg, Marijke P. Baltissen, Mojtaba Amini, Sytze de Roock, Femke van Wijk, Michiel Vermeulen, Alexander Marson, Jeroen P. Roose, and Yvonne Vercoulen. Dysregulated rasgrp1 expression through runx1 mediated transcription promotes autoimmunity. European Journal of Immunology, 51(2):471–482, November 2020. URL: http://dx.doi.org/10.1002/eji.201948451, doi:10.1002/eji.201948451. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/eji.201948451)

[5. (Hsu2023A) Tu Chun Hsu, Gisele O. L. Rodrigues, Hila Winer, Julie A. Hixon, Wenqing Li, Nadya I. Tarasova, and Scott K. Durum. A focused review of ras guanine nucleotide-releasing protein 1 in immune cells and cancer. International Journal of Molecular Sciences, 24(2):1652, January 2023. URL: http://dx.doi.org/10.3390/ijms24021652, doi:10.3390/ijms24021652. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms24021652)

[6. (Kuskonmaz2022First) Baris Kuskonmaz, Deniz Ayvaz, Fatma Visal Okur, Burça Aydın, Ilhan Tezcan, and Duygu Uckan Cetinkaya. First allogeneic hematopoietic stem cell transplantation in rasgrp1 deficiency: long-term follow-up. Bone Marrow Transplantation, 57(7):1210–1212, May 2022. URL: http://dx.doi.org/10.1038/s41409-022-01704-8, doi:10.1038/s41409-022-01704-8. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41409-022-01704-8)

[7. (Vercoulen2017A) Yvonne Vercoulen, Yasushi Kondo, Jeffrey S Iwig, Axel B Janssen, Katharine A White, Mojtaba Amini, Diane L Barber, John Kuriyan, and Jeroen P Roose. A histidine ph sensor regulates activation of the ras-specific guanine nucleotide exchange factor rasgrp1. eLife, September 2017. URL: http://dx.doi.org/10.7554/elife.29002, doi:10.7554/elife.29002. This article has 34 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.29002)